These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 24859616)

  • 21. Remote Ischemic Preconditioning To Reduce Contrast-Induced Nephropathy: A Randomized Controlled Trial.
    Menting TP; Sterenborg TB; de Waal Y; Donders R; Wever KE; Lemson MS; van der Vliet JA; Wetzels JF; SchultzeKool LJ; Warlé MC
    Eur J Vasc Endovasc Surg; 2015 Oct; 50(4):527-32. PubMed ID: 26015372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High dose statin loading prior to percutaneous coronary intervention decreases cardiovascular events: a meta-analysis of randomized controlled trials.
    Benjo AM; El-Hayek GE; Messerli F; DiNicolantonio JJ; Hong MK; Aziz EF; Herzog E; Tamis-Holland JE
    Catheter Cardiovasc Interv; 2015 Jan; 85(1):53-60. PubMed ID: 24272891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prasugrel versus clopidogrel in patients with ST-segment elevation myocardial infarction according to timing of percutaneous coronary intervention: a TRITON-TIMI 38 subgroup analysis (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis In Myocardial Infarction 38).
    Udell JA; Braunwald E; Antman EM; Murphy SA; Montalescot G; Wiviott SD
    JACC Cardiovasc Interv; 2014 Jun; 7(6):604-12. PubMed ID: 24947719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Remote ischemic postconditioning during percutaneous coronary interventions: remote ischemic postconditioning-percutaneous coronary intervention randomized trial.
    Lavi S; D'Alfonso S; Diamantouros P; Camuglia A; Garg P; Teefy P; Jablonsky G; Sridhar K; Lavi R
    Circ Cardiovasc Interv; 2014 Apr; 7(2):225-32. PubMed ID: 24692535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute multivessel revascularization improves 1-year outcome in ST-elevation myocardial infarction: a nationwide study cohort from the AMIS Plus registry.
    Jeger R; Jaguszewski M; Nallamothu BN; Lüscher TF; Urban P; Pedrazzini GB; Erne P; Radovanovic D;
    Int J Cardiol; 2014 Mar; 172(1):76-81. PubMed ID: 24461983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rationale and design of the on-treatment PLAtelet Reactivity-Guided Therapy Modification FOR ST-Segment Elevation Myocardial Infarction (PLATFORM) randomized trial.
    Mrdovic I; Savic L; Krljanac G; Asanin M; Cvetinovic N; Brdar N; Stojanovic M; Djuricic N; Stankovic S; Marinkovic J; Perunicic J
    J Interv Cardiol; 2013 Jun; 26(3):221-7. PubMed ID: 23373620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Late remote ischemic preconditioning provides benefit to patients undergoing elective percutaneous coronary intervention.
    Liu Z; Wang YL; Hua Q; Chu YY; Ji XM
    Cell Biochem Biophys; 2014 Sep; 70(1):437-42. PubMed ID: 25015066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-eluting versus bare-metal stents in large coronary arteries of patients with ST-segment elevation myocardial infarction: findings from the ICAS registry.
    Abe D; Sato A; Hoshi T; Maruta S; Misaki M; Kakefuda Y; Watabe H; Hiraya D; Sakai S; Kawabe M; Takeyasu N; Aonuma K
    J Cardiol; 2014 Nov; 64(5):377-83. PubMed ID: 24685689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Remote ischaemic postconditioning: does it protect against ischaemic damage in percutaneous coronary revascularisation? Randomised placebo-controlled clinical trial.
    Carrasco-Chinchilla F; Muñoz-García AJ; Domínguez-Franco A; Millán-Vázquez G; Guerrero-Molina A; Ortiz-García C; Enguix-Armada A; Alonso-Briales JH; Hernández-García JM; de Teresa-Galván E; Jiménez-Navarro MF
    Heart; 2013 Oct; 99(19):1431-7. PubMed ID: 23850844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does remote ischaemic preconditioning with postconditioning improve clinical outcomes of patients undergoing cardiac surgery? Remote Ischaemic Preconditioning with Postconditioning Outcome Trial.
    Hong DM; Lee EH; Kim HJ; Min JJ; Chin JH; Choi DK; Bahk JH; Sim JY; Choi IC; Jeon Y
    Eur Heart J; 2014 Jan; 35(3):176-83. PubMed ID: 24014392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of atrial fibrillation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (from the HORIZONS-AMI [Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction] trial).
    Rene AG; Généreux P; Ezekowitz M; Kirtane AJ; Xu K; Mehran R; Brener SJ; Stone GW
    Am J Cardiol; 2014 Jan; 113(2):236-42. PubMed ID: 24176066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction).
    Niccoli G; Rigattieri S; De Vita MR; Valgimigli M; Corvo P; Fabbiocchi F; Romagnoli E; De Caterina AR; La Torre G; Lo Schiavo P; Tarantino F; Ferrari R; Tomai F; Olivares P; Cosentino N; D'Amario D; Leone AM; Porto I; Burzotta F; Trani C; Crea F
    JACC Cardiovasc Interv; 2013 Jun; 6(6):580-9. PubMed ID: 23683738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of ranolazine in patients with incomplete revascularization after percutaneous coronary intervention: design and rationale of the Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (RIVER-PCI) trial.
    Weisz G; Farzaneh-Far R; Ben-Yehuda O; Debruyne B; Montalescot G; Lerman A; Mahmud E; Alexander KP; Ohman EM; White HD; Olmsted A; Walker GA; Stone GW
    Am Heart J; 2013 Dec; 166(6):953-959.e3. PubMed ID: 24268208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry.
    Lindsey JB; Marso SP; Pencina M; Stolker JM; Kennedy KF; Rihal C; Barsness G; Piana RN; Goldberg SL; Cutlip DE; Kleiman NS; Cohen DJ;
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1074-82. PubMed ID: 19926047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of distal embolization and distal protection on long-term outcome in patients with ST elevation myocardial infarction randomized to primary percutaneous coronary intervention--results from a randomized study.
    Lønborg J; Kelbæk H; Helqvist S; Holmvang L; Jørgensen E; Saunamäki K; Kløvgaard L; Kaltoft A; Bøtker HE; Lassen JF; Thuesen L; Terkelsen CJ; Kofoed KF; Clemmensen P; Køber L; Engstrøm T
    Eur Heart J Acute Cardiovasc Care; 2015 Apr; 4(2):180-8. PubMed ID: 25013089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: the Early Rapid ReversAl of platelet thromboSis with intravenous Elinogrel before PCI to optimize reperfusion in acute Myocardial Infarction (ERASE MI) pilot trial.
    Berger JS; Roe MT; Gibson CM; Kilaru R; Green CL; Melton L; Blankenship JD; Metzger DC; Granger CB; Gretler DD; Grines CL; Huber K; Zeymer U; Buszman P; Harrington RA; Armstrong PW
    Am Heart J; 2009 Dec; 158(6):998-1004.e1. PubMed ID: 19958867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rationale and design of the MGuard for acute ST elevation reperfusion MASTER trial.
    Costa JR; Abizaid A; Dudek D; Silber S; Leon MB; Stone GW
    Catheter Cardiovasc Interv; 2013 Aug; 82(2):184-90. PubMed ID: 23008177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radial versus femoral access for primary percutaneous interventions in ST-segment elevation myocardial infarction patients: a meta-analysis of randomized controlled trials.
    Karrowni W; Vyas A; Giacomino B; Schweizer M; Blevins A; Girotra S; Horwitz PA
    JACC Cardiovasc Interv; 2013 Aug; 6(8):814-23. PubMed ID: 23968700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization.
    Lenzen MJ; Boersma E; Bertrand ME; Maier W; Moris C; Piscione F; Sechtem U; Stahle E; Widimsky P; de Jaegere P; Scholte op Reimer WJ; Mercado N; Wijns W;
    Eur Heart J; 2005 Jun; 26(12):1169-79. PubMed ID: 15802360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.
    Kim JS; Kim J; Choi D; Lee CJ; Lee SH; Ko YG; Hong MK; Kim BK; Oh SJ; Jeon DW; Yang JY; Cho JR; Lee NH; Cho YH; Cho DK; Jang Y
    JACC Cardiovasc Interv; 2010 Mar; 3(3):332-9. PubMed ID: 20298994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.